Improving site selection in clinical studies: a standardised, objective, multistep method and first experience results

Anahí Hurtado-Chong, Alexander Joeris, Denise Hess, Michael Blauth, Anahí Hurtado-Chong, Alexander Joeris, Denise Hess, Michael Blauth

Abstract

Introduction: A considerable number of clinical studies experience delays, which result in increased duration and costs. In multicentre studies, patient recruitment is among the leading causes of delays. Poor site selection can result in low recruitment and bad data quality. Site selection is therefore crucial for study quality and completion, but currently no specific guidelines are available.

Material and methods: Selection of sites adequate to participate in a prospective multicentre cohort study was performed through an open call using a newly developed objective multistep approach. The method is based on use of a network, definition of objective criteria and a systematic screening process.

Illustrative example of the method at work: Out of 266 interested sites, 24 were shortlisted and finally 12 sites were selected to participate in the study. The steps in the process included an open call through a network, use of selection questionnaires tailored to the study, evaluation of responses using objective criteria and scripted telephone interviews. At each step, the number of candidate sites was quickly reduced leaving only the most promising candidates. Recruitment and quality of data went according to expectations in spite of the contracting problems faced with some sites.

Conclusion: The results of our first experience with a standardised and objective method of site selection are encouraging. The site selection method described here can serve as a guideline for other researchers performing multicentre studies.

Trial registration number: ClinicalTrials.gov: NCT02297581.

Keywords: clinical research; methodology; multicenter studies; site selection.

Conflict of interest statement

Competing interests: AH-Ch, AJ and DH are AOCID employees and receive salary from the AO Foundation.

© Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2017. All rights reserved. No commercial use is permitted unless otherwise expressly granted.

Figures

Figure 1
Figure 1
Steps of the site selection process. CIP, Clinical Investigation Plan.
Figure 2
Figure 2
Contact forms received from interested sites divided by geographical region.
Figure 3
Figure 3
Application of strict criterion to filter out sites and number of sites remaining at each step. AE, advers events; GFC, geriatric fracture centres; UCC, usual care centres.
Figure 4
Figure 4
Patient enrolment until February 2017.
Figure 5
Figure 5
Patients recruited by study site until February 2017.

References

    1. Quintiles. Quintiles Right Start [Webpage]. (cited 27 Apr 2016).
    1. Goldfarb NM. Trials in the fast lane: “Accelerating clinical trials: budgets, patient recruitment and productivity". J Clin Res Best Pract 2016;1 .
    1. Farrell B, Kenyon S, Shakur H, et al. . Managing clinical trials. Trials 2010;11:78 10.1186/1745-6215-11-78
    1. Gheorghiade M, Vaduganathan M, Greene SJ, et al. . Site selection in global clinical trials in patients hospitalized for heart failure: perceived problems and potential solutions. Heart Fail Rev 2014;19:135–52. 10.1007/s10741-012-9361-8
    1. Miseta E. Bring Down The Cost Of Clinical Trials With Improved Site Selection: Clinical Leader. 2013. (cited 27 Apr 2013).
    1. Phillips K. Top 5 Metrics Your Site Should be Using Today Forte Research Systems. 2013. (cited 27 Apr 2016).
    1. Gehring M, Taylor RS, Mellody M, et al. . Factors influencing clinical trial site selection in Europe: the Survey of Attitudes towards Trial sites in Europe (the SAT-EU Study). BMJ Open 2013;3:e002957 10.1136/bmjopen-2013-002957
    1. Maskell NA, Jones EL, Davies RJ. Variations in experience in obtaining local ethical approval for participation in a multi-centre study. QJM 2003;96:305–7. 10.1093/qjmed/hcg042
    1. Potter JS, Donovan DM, Weiss RD, et al. . Site selection in community-based clinical trials for substance use disorders: strategies for effective site selection. Am J Drug Alcohol Abuse 2011;37:400–7. 10.3109/00952990.2011.596975
    1. Boutron I, Ravaud P, Nizard R. The design and assessment of prospective randomised, controlled trials in orthopaedic surgery. J Bone Joint Surg Br 2007;89:858–63. 10.1302/0301-620X.89B7.19440
    1. Joeris A, Hurtado-Chong A, Hess D, et al. . Evaluation of the geriatric co-management for patients with fragility fractures of the proximal femur (geriatric fracture center (GFC) concept): protocol for a prospective multicenter cohort study. BMJ Open 2017:e014795 10.1136/bmjopen2016-014795
    1. Harris PA, Taylor R, Thielke R, et al. . Research electronic data capture (REDCap)--a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform 2009;42:377–81. 10.1016/j.jbi.2008.08.010
    1. Warden D, Trivedi MH, Greer TL, et al. . Rationale and methods for site selection for a trial using a novel intervention to treat stimulant abuse. Contemp Clin Trials 2012;33:29–37. 10.1016/j.cct.2011.08.011
    1. Berthon-Jones N, Courtney-Vega K, Donaldson A, et al. . Assessing site performance in the Altair study, a multinational clinical trial. Trials 2015;16:138 10.1186/s13063-015-0653-x
    1. Treweek S, Mitchell E, Pitkethly M, et al. . Strategies to improve recruitment to randomised controlled trials. Cochrane Database Syst Rev 2010:MR000013 10.1002/14651858.MR000013.pub4
    1. Kasenda B, von Elm E, You J, et al. . Prevalence, characteristics, and publication of discontinued randomized trials. JAMA 2014;311:1045–51. 10.1001/jama.2014.1361
    1. Bennette CS, Ramsey SD, McDermott CL, et al. . Predicting Low Accrual in the National Cancer Institute's Cooperative Group Clinical Trials. J Natl Cancer Inst 2016;108:djv324 10.1093/jnci/djv324
    1. Schroen AT, Petroni GR, Wang H, et al. . Achieving sufficient accrual to address the primary endpoint in phase III clinical trials from U.S. Cooperative Oncology Groups. Clin Cancer Res 2012;18:256–62. 10.1158/1078-0432.CCR-11-1633
    1. Clinipace. Site selection and Management, 2016. (cited 27 Apr 2016).

Source: PubMed

3
Abonner